飛捷 6206 - 股息配發率

現金殖利率: 4.74%、總殖利率: 4.74%、5年平均現金配發率: 92.35%
要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)

	EPS YoY		現金股利 YoY		現金配發率 YoY		全部配發率 YoY
2023 (10)	3.48	-51.67	4.00	-27.27	114.94	50.47	114.94	50.47
2022 (9)	7.20	51.9	5.50	37.5	76.39	-9.48	76.39	-9.48
2021 (8)	4.74	15.89	4.00	0.0	84.39	-13.71	84.39	-13.71
2020 (7)	4.09	-19.8	4.00	-11.11	97.80	10.84	97.80	10.84
2019 (6)	5.10	-8.11	4.50	-10.0	88.24	-2.06	88.24	-2.06
2018 (5)	5.55	10.34	5.00	11.11	90.09	0.7	90.09	0.7
2017 (4)	5.03	-16.03	4.50	-10.0	89.46	7.18	89.46	7.18
2016 (3)	5.99	-13.06	5.00	-16.67	83.47	-4.15	83.47	-4.15

每股盈餘-近20季

	EPS QoQ YoY			本業EPS QoQ YoY			累計EPS QoQ YoY
23Q4 (20)	1.20	34.83	84.62	1.41	116.92	76.25	3.51	51.95	-51.85
23Q3 (19)	0.89	-16.04	-59.91	0.65	-17.72	-63.89	2.31	62.68	-65.21
23Q2 (18)	1.06	186.49	-57.43	0.79	119.44	-65.95	1.42	283.78	-67.8
23Q1 (17)	0.37	-43.08	-80.73	0.36	-55.0	-78.31	0.37	-94.92	-80.73
22Q4 (16)	0.65	-70.72	-62.21	0.80	-55.56	-53.76	7.29	9.79	52.83
22Q3 (15)	2.22	-10.84	58.57	1.80	-22.41	28.57	6.64	50.57	116.99
22Q2 (14)	2.49	29.69	137.14	2.32	39.76	118.87	4.41	129.69	165.66
22Q1 (13)	1.92	11.63	220.0	1.66	-4.05	186.21	1.92	-59.75	220.0
21Q4 (12)	1.72	22.86	129.33	1.73	23.57	124.68	4.77	55.88	15.78
21Q3 (11)	1.40	33.33	19.66	1.40	32.08	50.54	3.06	84.34	-9.2
21Q2 (10)	1.05	75.0	36.36	1.06	82.76	27.71	1.66	176.67	-24.55
21Q1 (9)	0.60	-20.0	-58.04	0.58	-24.68	-55.73	0.60	-85.44	-58.04
20Q4 (8)	0.75	-35.9	-31.82	0.77	-17.2	-44.2	4.12	22.26	-20.0
20Q3 (7)	1.17	51.95	4.46	0.93	12.05	-19.13	3.37	53.18	-16.79
20Q2 (6)	0.77	-46.15	-49.67	0.83	-36.64	-42.76	2.20	53.85	-24.91
20Q1 (5)	1.43	30.0	2.14	1.31	-5.07	-3.68	1.43	-72.23	2.14
19Q4 (4)	1.10	-1.79	0.0	1.38	20.0	0.0	5.15	27.16	0.0
19Q3 (3)	1.12	-26.8	0.0	1.15	-20.69	0.0	4.05	38.23	0.0
19Q2 (2)	1.53	9.29	0.0	1.45	6.62	0.0	2.93	109.29	0.0
19Q1 (1)	1.40	0.0	0.0	1.36	0.0	0.0	1.40	0.0	0.0

年/月	營收	月增率(%)	去年同期年增率(%)	累計營收	累計營收年增率(%)	近三月累計營收	存貨銷售比	備註(年增率變動50%需說明原因)
2024/3	3.85	31.74	49.31	10.13	31.64	10.13	N/A	-
2024/2	2.92	-13.03	19.84	6.28	22.74	9.09	N/A	-
2024/1	3.36	19.59	25.38	3.36	25.38	9.81	N/A	-
2023/12	2.81	-22.7	19.96	34.88	-37.08	9.95	0.56	-
2023/11	3.64	3.73	29.36	32.07	-39.59	9.72	0.57	-
2023/10	3.5	35.59	-23.52	28.44	-43.44	8.94	0.62	-
2023/9	2.58	-9.3	-45.81	24.93	-45.44	8.03	0.85	-
2023/8	2.85	9.94	-39.68	22.35	-45.4	8.68	0.79	-
2023/7	2.59	-20.07	-44.1	19.5	-46.14	9.33	0.73	-
2023/6	3.24	-7.26	-44.42	16.91	-46.45	9.21	0.76	-
2023/5	3.5	41.4	-39.26	13.67	-46.91	8.55	0.82	-
2023/4	2.47	-4.11	-49.01	10.17	-49.11	7.49	0.93	-
2023/3	2.58	5.73	-49.3	7.7	-49.14	7.7	1.03	-
2023/2	2.44	-9.01	-44.46	5.12	-49.06	7.46	1.06	-
2023/1	2.68	14.42	-52.62	2.68	-52.62	7.83	1.01	去年基期相對偏高
2022/12	2.34	-16.64	-51.63	55.44	6.92	9.74	0.94	去年基期相對偏高
2022/11	2.81	-38.67	-53.07	53.1	12.95	12.16	0.76	去年基期相對偏高
2022/10	4.58	-3.92	-20.92	50.29	22.59	14.08	0.65	-
2022/9	4.77	0.96	-12.0	45.71	29.76	14.13	0.83	-
2022/8	4.72	1.89	-4.58	40.94	37.35	15.2	0.78	-
2022/7	4.64	-20.52	16.97	36.21	45.71	16.23	0.73	-
2022/6	5.83	1.33	50.22	31.58	51.16	16.44	0.71	去年疫情基期低,今年恢復正常
2022/5	5.76	18.71	51.55	25.74	51.38	15.69	0.74	去年疫情基期低，今年恢復正常
2022/4	4.85	-4.66	19.55	19.99	51.33	14.33	0.81	去年疫情基期低,今年恢復正常
2022/3	5.09	15.83	65.97	15.14	65.42	15.14	0.87	去年疫情導致基期低，今年恢復正常
2022/2	4.39	-22.38	67.11	10.05	65.14	14.89	0.88	去年疫情導致基期低，今年恢復正常
2022/1	5.66	16.82	63.64	5.66	63.64	16.49	0.79	去年疫情導致基期低，今年恢復正常
2021/12	4.84	-19.12	66.78	51.85	16.96	16.63	0.86	去年疫情導致基期低，今年恢復正常
2021/11	5.99	3.33	71.12	47.01	13.47	17.2	0.83	去年疫情導致基期低，今年恢復正常
2021/10	5.8	6.9	50.58	41.02	8.15	16.17	0.88	去年疫情導致基期低，今年恢復正常
2021/9	5.42	9.48	31.86	35.22	3.36	14.34	1.07	-
2021/8	4.95	24.9	22.98	29.8	-0.54	12.8	1.2	-
2021/7	3.96	2.06	2.59	24.85	-4.19	11.65	1.32	-
2021/6	3.88	2.23	16.74	20.89	-5.38	11.74	1.0	-
2021/5	3.8	-6.35	24.11	17.0	-9.31	10.92	1.08	-
2021/4	4.06	32.35	29.95	13.21	-15.83	9.75	1.21	-
2021/3	3.06	16.62	-25.39	9.15	-27.2	9.15	0.92	-
2021/2	2.63	-23.99	-31.54	6.09	-28.08	8.99	0.94	-
2021/1	3.46	19.06	-25.21	3.46	-25.21	9.86	0.86	-
2020/12	2.9	-17.02	-33.22	44.33	-16.83	10.25	0.64	-
2020/11	3.5	-9.06	-4.19	41.43	-15.38	11.46	0.57	-
2020/10	3.85	-6.38	-17.22	37.93	-16.28	11.98	0.55	-
2020/9	4.11	2.1	2.71	34.08	-16.17	12.0	0.69	-
2020/8	4.03	4.2	-2.17	29.97	-18.23	11.22	0.74	-
2020/7	3.86	16.14	-8.71	25.94	-20.26	10.25	0.81	-
2020/6	3.33	8.68	-28.7	22.08	-21.99	9.51	0.91	-
2020/5	3.06	-1.95	-33.5	18.75	-20.67	10.29	0.84	-
2020/4	3.12	-24.0	-33.53	15.69	-17.57	11.07	0.78	-
2020/3	4.11	7.0	-20.79	12.57	-12.34	12.57	0.71	-
2020/2	3.84	-16.96	7.18	8.46	-7.55	12.81	0.7	-
2020/1	4.62	6.3	-17.02	4.62	-17.02	12.62	0.71	-
2019/12	4.35	19.05	33.9	53.3	-18.86	12.65	0.56	-
2019/11	3.65	-21.43	3.95	48.96	-21.6	12.3	0.58	-
2019/10	4.65	16.16	-3.12	45.3	-23.13	12.77	0.56	-
2019/9	4.0	-2.75	-5.98	40.65	-24.9	12.35	0.63	-
2019/8	4.12	-2.76	-28.99	36.65	-26.52	13.01	0.6	-
2019/7	4.23	-9.29	-21.91	32.54	-26.19	13.5	0.58	-
2019/6	4.67	1.37	-35.56	28.3	-26.79	13.96	0.55	-
2019/5	4.6	-1.99	-33.55	23.64	-24.77	0.0	N/A	-
2019/4	4.7	-9.44	-34.79	19.04	-22.29	0.0	N/A	-